COCH — Envoy Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $46.26m
- $46.13m
- $0.32m
Annual cashflow statement for Envoy Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -8.68 | -15.9 | -29.9 |
| Depreciation | |||
| Non-Cash Items | 1.75 | 7.2 | 13.1 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -0.082 | -0.16 | -0.958 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | -6.94 | -8.8 | -17.7 |
| Capital Expenditures | -0.125 | -0.218 | -0.153 |
| Purchase of Fixed Assets | |||
| Cash from Investing Activities | -0.125 | -0.218 | -0.153 |
| Financing Cash Flow Items | 0.058 | 0.092 | 11.7 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 8.06 | 8.09 | 21.8 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0.987 | -0.938 | 4.04 |